Related Content
Learn more
poster
High throughput tissue phenotyping and imaging of the tumor immune microenvironment using novel FlexVUE™multiplexed immunofluorescence assays
Presented at AACR 2022
Learn more
poster
Measuring concordance of CD8 and PD-L1 expression in Non-Small Cell Lung cancer between a novel multiplex immunofluorescence assay and a brightfield laboratory developed test
Presented at AACR 2020
Learn more
poster
A multiplex immunofluorescence assay to assess immune checkpoint inhibitor targeted CD8 activation and tumor co-localization in FFPE tissues Copy
Learn more
webinar
Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer
Length: 46 minutes
